Angiodynamics (ANGO) 18.88 $ANGO
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 167.49 (-1.66), VASC: 27.50 (-0.90), ANGO: 18.88 (+0.15), MMSI: 16.41 (+0.02)
AngioDynamics (ANGO) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Thu Dec 11, 8:47AM CST
Trade-Ideas LLC identified AngioDynamics (ANGO) as a strong and under the radar candidate
ANGO: 18.88 (+0.15)
AngioDynamics Awarded HealthTrust PICC Contract
GlobeNewswire - Tue Dec 09, 5:33AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC (peripherally inserted central catheter) products.
ANGO: 18.88 (+0.15)
Angiodynamics Shares Up 14.5% Since SmarTrend's Buy Recommendation (ANGO)
Comtex SmarTrend(R) - Fri Dec 05, 5:11PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.54% as of today's recent price of $17.45.
ANGO: 18.88 (+0.15)
Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 1:40PM CST
Hologic's (HOLX) international business, which had been underperforming over the past few quarters, showed a turnaround in the fourth quarter.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), ANGO: 18.88 (+0.15), HOLX: 25.85 (-0.52)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into AngioDynamics Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Fri Dec 05, 12:57PM CST
Levi & Korsinsky, LLP is investigating AngioDynamics Inc. (NasdaqGS:ANGO) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
ANGO: 18.88 (+0.15)
Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:10PM CST
Thoratec Corp (THOR) recently completed enrolment of 50 patients under the HeartMate III CE Mark trial at ten sites across Europe, Canada, and Australia.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), THOR: 31.61 (-0.07), ANGO: 18.88 (+0.15)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 85.15 (-1.08), EW: 128.87 (-3.20), ARAY: 6.95 (+0.04), ANGO: 18.88 (+0.15)
Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 1:40PM CST
Cepheid's (CPHD) Xpert Norovirus test comes as the much-desired solution, with its capacity to determine the presence of Norovirus and accurately isolate the different groups of this pathogen
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), CPHD: 49.73 (-1.24), ANGO: 18.88 (+0.15)
Luminex Grows on Product Launches & Strategic Partnerships - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:00PM CST
We believe that Austin, TX-based Luminex Corporation (LMNX) has an interesting product pipeline and will significantly benefit from new products like ARIES and NxTAG.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), LMNX: 17.94 (-0.29), ANGO: 18.88 (+0.15)
14.9% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO)
Comtex SmarTrend(R) - Fri Nov 28, 4:56PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.87% as of today's recent price of $17.50.
ANGO: 18.88 (+0.15)
Edwards Lifesciences Strong on Robust Q3, Raised Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 2:50PM CST
Edwards Lifesciences (EW) reported better-than-expected third-quarter 2014 financial results on Oct 23.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15)
Fresenius Medical (FMS) Scales 52-Week High on Strong Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 9:00AM CST
Shares of Fresenius Medical Care AG & Co. KGAA (FMS) reached a 52-week high of $37.20 on Nov 26, 2014.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), FMS: 36.63 (-0.63), ANGO: 18.88 (+0.15)
Oxford Immunotec (OXFD) Looks Good: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 8:46AM CST
Oxford Immunotec (OXFD) was a big mover last session, as the company saw its shares rise roughly 6% on the day.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), OXFD: 10.92 (unch), ANGO: 18.88 (+0.15)
AngioDynamics (ANGO) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 7:36AM CST
AngioDynamics (ANGO) Stock: Moving Average Crossover Alert
ANGO: 18.88 (+0.15)
Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 1:50PM CST
Cepheid's (CPHD) Xpert Flu/RSV XC test can accurately detect the presence of Flu A, Flu B as well as respiratory syncytial virus (RSV) infection in a patient's body.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), CPHD: 49.73 (-1.24), ANGO: 18.88 (+0.15)
Sirona Dental Lags Q4 Earnings by a Penny, Tops Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 8:30AM CST
Sirona Dental Systems Inc. (SIRO) reported adjusted earnings per share (EPS) of 90 cents for the fourth quarter of fiscal 2014, which fell shy of the Zacks Consensus Estimate of 91 cents.
SIRO: 86.33 (-0.78), PDCO: 47.44 (-0.72), ANGO: 18.88 (+0.15), HSIC: 133.80 (-1.20)
TearLab (TEAR) in Focus: Stock Moves 9.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:30AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.37 (-0.03), TEAR: 2.39 (+0.02), FLDM: 27.21 (-0.04), ANGO: 18.88 (+0.15)
AngioDynamics to Present at 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 25, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, at 2:30 p.m. (ET). The conference will be held at the New York Palace Hotel in New York City.
ANGO: 18.88 (+0.15)
Cyberonics Slumps: CYBX Falls 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 7:50AM CST
Cyberonics has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past 24 hours
ETRM: 1.37 (-0.03), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15), CYBX: 53.76 (+0.08)
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 167.49 (-1.66), VASC: 27.50 (-0.90), ANGO: 18.88 (+0.15), MMSI: 16.41 (+0.02)
AngioDynamics (ANGO) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Thu Dec 11, 8:47AM CST
Trade-Ideas LLC identified AngioDynamics (ANGO) as a strong and under the radar candidate
ANGO: 18.88 (+0.15)
AngioDynamics Awarded HealthTrust PICC Contract
GlobeNewswire - Tue Dec 09, 5:33AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC (peripherally inserted central catheter) products.
ANGO: 18.88 (+0.15)
Angiodynamics Shares Up 14.5% Since SmarTrend's Buy Recommendation (ANGO)
Comtex SmarTrend(R) - Fri Dec 05, 5:11PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.54% as of today's recent price of $17.45.
ANGO: 18.88 (+0.15)
Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 1:40PM CST
Hologic's (HOLX) international business, which had been underperforming over the past few quarters, showed a turnaround in the fourth quarter.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), ANGO: 18.88 (+0.15), HOLX: 25.85 (-0.52)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into AngioDynamics Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Fri Dec 05, 12:57PM CST
Levi & Korsinsky, LLP is investigating AngioDynamics Inc. (NasdaqGS:ANGO) in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company.
ANGO: 18.88 (+0.15)
Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:10PM CST
Thoratec Corp (THOR) recently completed enrolment of 50 patients under the HeartMate III CE Mark trial at ten sites across Europe, Canada, and Australia.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), THOR: 31.61 (-0.07), ANGO: 18.88 (+0.15)
Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:50PM CST
Varian Medical Systems (VAR) will showcase new technologies in the ongoing (Nov 30 through Dec 5) annual meet of the Radiological Society of North America (RSNA).
VAR: 85.15 (-1.08), EW: 128.87 (-3.20), ARAY: 6.95 (+0.04), ANGO: 18.88 (+0.15)
Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 1:40PM CST
Cepheid's (CPHD) Xpert Norovirus test comes as the much-desired solution, with its capacity to determine the presence of Norovirus and accurately isolate the different groups of this pathogen
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), CPHD: 49.73 (-1.24), ANGO: 18.88 (+0.15)
Luminex Grows on Product Launches & Strategic Partnerships - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:00PM CST
We believe that Austin, TX-based Luminex Corporation (LMNX) has an interesting product pipeline and will significantly benefit from new products like ARIES and NxTAG.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), LMNX: 17.94 (-0.29), ANGO: 18.88 (+0.15)
14.9% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO)
Comtex SmarTrend(R) - Fri Nov 28, 4:56PM CST
SmarTrend identified an Uptrend for Angiodynamics (NASDAQ:ANGO) on October 13th, 2014 at $15.24. In approximately 2 months, Angiodynamics has returned 14.87% as of today's recent price of $17.50.
ANGO: 18.88 (+0.15)
Edwards Lifesciences Strong on Robust Q3, Raised Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 2:50PM CST
Edwards Lifesciences (EW) reported better-than-expected third-quarter 2014 financial results on Oct 23.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15)
Fresenius Medical (FMS) Scales 52-Week High on Strong Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 9:00AM CST
Shares of Fresenius Medical Care AG & Co. KGAA (FMS) reached a 52-week high of $37.20 on Nov 26, 2014.
FLDM: 27.21 (-0.04), EW: 128.87 (-3.20), FMS: 36.63 (-0.63), ANGO: 18.88 (+0.15)
Oxford Immunotec (OXFD) Looks Good: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 8:46AM CST
Oxford Immunotec (OXFD) was a big mover last session, as the company saw its shares rise roughly 6% on the day.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), OXFD: 10.92 (unch), ANGO: 18.88 (+0.15)
AngioDynamics (ANGO) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 7:36AM CST
AngioDynamics (ANGO) Stock: Moving Average Crossover Alert
ANGO: 18.88 (+0.15)
Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 1:50PM CST
Cepheid's (CPHD) Xpert Flu/RSV XC test can accurately detect the presence of Flu A, Flu B as well as respiratory syncytial virus (RSV) infection in a patient's body.
ETRM: 1.37 (-0.03), FLDM: 27.21 (-0.04), CPHD: 49.73 (-1.24), ANGO: 18.88 (+0.15)
Sirona Dental Lags Q4 Earnings by a Penny, Tops Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 8:30AM CST
Sirona Dental Systems Inc. (SIRO) reported adjusted earnings per share (EPS) of 90 cents for the fourth quarter of fiscal 2014, which fell shy of the Zacks Consensus Estimate of 91 cents.
SIRO: 86.33 (-0.78), PDCO: 47.44 (-0.72), ANGO: 18.88 (+0.15), HSIC: 133.80 (-1.20)
TearLab (TEAR) in Focus: Stock Moves 9.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:30AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.37 (-0.03), TEAR: 2.39 (+0.02), FLDM: 27.21 (-0.04), ANGO: 18.88 (+0.15)
AngioDynamics to Present at 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 25, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a Q&A session at the Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, at 2:30 p.m. (ET). The conference will be held at the New York Palace Hotel in New York City.
ANGO: 18.88 (+0.15)
Cyberonics Slumps: CYBX Falls 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 7:50AM CST
Cyberonics has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past 24 hours
ETRM: 1.37 (-0.03), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15), CYBX: 53.76 (+0.08)
